228760 — Genomictree Income Statement
0.000.00%
Last trade - 00:00- KR₩350bn
- KR₩256bn
- KR₩2bn
Annual income statement for Genomictree, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,239 | 5,140 | 29,866 | 3,418 | 2,362 |
| Cost of Revenue | |||||
| Gross Profit | 55.2 | 2,515 | 24,994 | -270 | -727 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 13,647 | 14,995 | 25,582 | 16,163 | 17,676 |
| Operating Profit | -12,409 | -9,855 | 4,284 | -12,745 | -15,313 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11,722 | -11,424 | -3,693 | -9,503 | -10,389 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11,723 | -11,425 | -6,237 | -9,007 | -10,390 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -11,795 | -11,425 | -6,631 | -8,756 | -10,242 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11,795 | -11,425 | -6,631 | -8,756 | -10,242 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -590 | -554 | -371 | -523 | -429 |
| Dividends per Share |